LifeArc

LifeArc® is a self-funded medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and drug-resistant infections.We aim to deliver this by conducting and funding pioneering research, and working with partners to accelerate the translation of scientific breakthroughs into new tests and treatments.Our vision is a world where people living with rare diseases and drug-resistant infections can access effective, life-changing treatments faster.We have been doing this for more than 25 years and our work has resulted in a diagnostic for antibiotic resistance and four licensed medicines – Keytruda®( cancer), Actemra® (rheumatoid arthritis), Tysabri® (multiple sclerosis) and Entyvio® (Crohn’s disease).Find out more about our work at www.lifearc.org or follow us on LinkedIn, X (@lifearc1) or Bluesky (@lifearc.bsky.social)